DOCSUN BioMed Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2022

Location

Cambridge MA US

Primary Industry

Healthcare IT

About

Based in Massachusetts, US, and founded in 2019, DOCSUN BioMed Ltd., operates as a provider of various health monitoring tools that use embedded human knowledge and artificial intelligence to provide customized personal health management solutions. In October 2022, DOCSUN BioMed Ltd. raised series A funding led by investor, United Crest Healthcare. As of 2022, the company is led by its interim CEO, James Weis. The company offers an artificial intelligence-based health monitoring system used in gyms and sports facilities, automobiles, and public places like schools, offices, malls, hotels, airports, and many more. The company also provides a home personal health management solution and a telehealth portal that allows users to check their patients remotely and make health assessments. The company plans to use October 2022 funding to increase its reach and fulfill the goal of more accessible healthcare to those who need it most.

Current Investors

United Crest Capital

Request a demo to show more

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Monitoring Equipment, Medical Software

Website

www.docsun.health

Verticals

Cloud Computing, HealthTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.